236 related articles for article (PubMed ID: 6266253)
21. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
22. Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin.
Jones WB; Lewis JL; Lehr M
Am J Obstet Gynecol; 1975 Mar; 121(5):669-73. PubMed ID: 46716
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
[TBL] [Abstract][Full Text] [Related]
24. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
25. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay of hCG as an early diagnosis of cerebral metastases in choriocarcinoma patients.
Soma H; Takayama M; Tokoro K; Kikuchi T; Kikuchi K; Saegusa H
Acta Obstet Gynecol Scand; 1980; 59(5):445-8. PubMed ID: 7446011
[TBL] [Abstract][Full Text] [Related]
27. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
[TBL] [Abstract][Full Text] [Related]
28. Isoelectric heterogenity of human chorionic gonadotropin: Presence of choriocarcinoma specific components.
Yazaki K; Yazaki C; Wakabayashi K; Igarashi M
Am J Obstet Gynecol; 1980 Sep; 138(2):189-94. PubMed ID: 6252781
[TBL] [Abstract][Full Text] [Related]
29. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
Dawood MY; Saxena BB; Landesman R
Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy.
Khazaeli MB; Hedayat MM; Hatch KD; To AC; Soong SJ; Shingleton HM; Boots LR; LoBuglio AF
Am J Obstet Gynecol; 1986 Aug; 155(2):320-4. PubMed ID: 3017111
[TBL] [Abstract][Full Text] [Related]
31. [Actual possibilities of prevention and treatment of trophoblastic disease (author's transl)].
Kudela M; Talas M; Fingerová H
Cesk Gynekol; 1981 Mar; 46(2):108-11. PubMed ID: 6263504
[No Abstract] [Full Text] [Related]
32. Regression pattern of beta human chorionic gonadotrophin in blood after chemotherapy for gestational trophoblastic neoplasia.
Burrows A; Faddy MJ; Khoo SK
Aust N Z J Obstet Gynaecol; 1996 Aug; 36(3):331-4. PubMed ID: 8883763
[TBL] [Abstract][Full Text] [Related]
33. A highly sensitive and specific sandwich enzyme immunoassay for detection of human chorionic gonadotropin in trophoblastic disease.
Ibuki Y; Yazaki K; Igarashi M
Asia Oceania J Obstet Gynaecol; 1990 Mar; 16(1):49-56. PubMed ID: 2160806
[TBL] [Abstract][Full Text] [Related]
34. Unusual molecular forms of hCG in gestational trophoblastic neoplasia.
Amr S; Rosa C; Wehmann R; Birken S; Nisula B
Ann Endocrinol (Paris); 1984; 45(4-5):321-6. PubMed ID: 6085541
[TBL] [Abstract][Full Text] [Related]
35. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
Quigley MM; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
[TBL] [Abstract][Full Text] [Related]
36. Gestational trophoblastic neoplasms.
Hilgers RD; Lewis JL
Gynecol Oncol; 1974 Dec; 2(4):460-75. PubMed ID: 4376997
[TBL] [Abstract][Full Text] [Related]
37. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.
Rotmensch S; Cole LA
Lancet; 2000 Feb; 355(9205):712-5. PubMed ID: 10703803
[TBL] [Abstract][Full Text] [Related]
38. [The determination of the recognition site of an antiserum detecting desialylation on O-glycosidic carbohydrates of hCG and its clinical applications. The relationship between the presence of asialo-hCG and malignant change in trophoblastic disease].
Takeuchi Y; Matsuura S; Nishimura R; Mochizuki M
Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1046-57. PubMed ID: 6097485
[TBL] [Abstract][Full Text] [Related]
39. Pregnancy-specific beta 1-glycoprotein in complicated early pregnancy and trophoblastic disease.
Seppälä M; Rutanen EM; Stenman UH; Siiteri JE
Ric Clin Lab; 1982; 12(1):251-4. PubMed ID: 6283617
[No Abstract] [Full Text] [Related]
40. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
